Steep Hill Receives United Patients Group Seal of Approval

Steep Hill Labs Receive United Patients Group Seal of Approval

United Patients Group, the leading medical cannabis information and educational site, is proud to award Steep Hill Labs its Seal of Approval. United Patients Group’s founder John Malanca says “Steep Hill…”.

Steep Hill is an independently owned and operated analysis, biotechnology, and research and development facility. Their mission is to empower cultivators, dispensaries, manufacturers, and consumers with a transparent understanding of science.

Steep Hill’s core business is testing and analyzing medical and recreational marijuana to ensure compliance with public safety standards. In addition to its core business, Steep Hill is also an innovative R&D Lab that has developed and commercialized two highly-differentiated and proprietary products: the QuantaCann™ and the GenKit™.

About Steep Hill Labs
Steep Hill is the country’s leading cannabis science and technology firm. Steep Hill opened the first commercial cannabis lab in the United States in 2008, and now has company-owned labs in Berkeley, CA, and Seattle, WA, with licensed labs in Honolulu, HI, Columbia, MD, Las Vegas, NV, and Albuquerque, NM, visit: to learn more.

About United Patients Group
United Patients Group is the leading medical cannabis information and educational site that is dedicated to providing the most professional and safe resource for Medical Cannabis information.

While most online medical cannabis sites cater to patients already familiar with medical cannabis, the website is a comprehensive and easy-to-use information source for people of all ages and experience levels, from novice users to experienced industry professionals. The site’s News, Resource, and Blog pages introduce new patients to the ins and outs of medical cannabis healthcare, while helping experienced providers stay abreast of the latest developments in THC and CBD therapies.